These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2092446)

  • 1. [Cytostatic drug therapy in the aged].
    Wilmanns W
    Verh Dtsch Ges Inn Med; 1990; 96():286-94. PubMed ID: 2092446
    [No Abstract]   [Full Text] [Related]  

  • 2. [Limits and value of chemotherapy in elderly patients].
    Engert A; Schnell R; Lathan B; Diehl V
    Med Klin (Munich); 1994 Nov; 89(11):603-10. PubMed ID: 7815990
    [No Abstract]   [Full Text] [Related]  

  • 3. The evolution of curative cancer therapy.
    Frei E
    Mt Sinai J Med; 1992 Oct; 59(5):408-11. PubMed ID: 1435837
    [No Abstract]   [Full Text] [Related]  

  • 4. [Methods for optimizing cytostatic drug therapy].
    Lipp HP
    Med Monatsschr Pharm; 1995 Oct; 18(10):282-91. PubMed ID: 7476654
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy with cytostatic drugs in the elderly].
    Sauer H
    Internist (Berl); 1991 Aug; 32(8):479-85. PubMed ID: 1938269
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cytostatic chemotherapy in advanced age].
    Sauer H
    Geburtshilfe Frauenheilkd; 1995 Jan; 55(1):M1-5. PubMed ID: 7705590
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase I clinical and pharmacokinetic study of combination chemotherapy with topotecan and ifosfamide in patients with progressive or relapsed solid tumors.
    Schneider CP; Merkel U; Grübner U; Kath R; Höffken K; Hoffmann A
    J Cancer Res Clin Oncol; 2002 Jun; 128(6):313-8. PubMed ID: 12073049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot clinical/pharmacological study of the protein kinase C-specific inhibitor safingol alone and in combination with doxorubicin.
    Schwartz GK; Ward D; Saltz L; Casper ES; Spiess T; Mullen E; Woodworth J; Venuti R; Zervos P; Storniolo AM; Kelsen DP
    Clin Cancer Res; 1997 Apr; 3(4):537-43. PubMed ID: 9815717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The leucocyte nadir, a predictor of chemotherapy efficacy?
    Kvinnsland S
    Br J Cancer; 1999 Aug; 80(11):1681. PubMed ID: 10468282
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mono-polychemotherapeutic treatment? The opportunities and limits].
    Carreca I; Dispenza J; Agueli R; Cucciarrè S
    Minerva Med; 1999; 90(7-8):203-4. PubMed ID: 10719418
    [No Abstract]   [Full Text] [Related]  

  • 11. [Severe neutropenia following cytostatic drug therapy--clinical symptoms, follow-up and prognosis in 26 patients of a district hospital].
    Radke EU; Papke J
    Z Gesamte Inn Med; 1990 Apr; 45(8):219-22. PubMed ID: 2378134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer chemotherapy in the elderly.
    Walsh SJ; Begg CB; Carbone PP
    Semin Oncol; 1989 Feb; 16(1):66-75. PubMed ID: 2645651
    [No Abstract]   [Full Text] [Related]  

  • 13. [Criteria for the determination of the efficacy of solid cancer chemotherapy].
    Saito T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):626-34. PubMed ID: 3954385
    [No Abstract]   [Full Text] [Related]  

  • 14. Some considerations on the role of chemotherapy in individualization of cancer therapy.
    Tagnon HJ
    Strahlentherapie; 1984 Nov; 160(11):681-3. PubMed ID: 6506107
    [No Abstract]   [Full Text] [Related]  

  • 15. [Side effects and complications of intra-arterial tumor therapy--experiences with 577 interventions].
    Görich J; Hasan I; Sittek H; Harder T; Rieber A; Hartlapp HJ; Keilholz U; Kunze V; Brado M; Reiser M
    Rontgenpraxis; 1995 May; 48(5):132-45. PubMed ID: 7792665
    [No Abstract]   [Full Text] [Related]  

  • 16. [Supportive therapy in onco-hematology].
    István L
    Orv Hetil; 1988 Nov; 129(48):2559-68. PubMed ID: 3059258
    [No Abstract]   [Full Text] [Related]  

  • 17. [Principles of adjuvant drug therapy in breast cancer].
    Castiglione M; Schnürch HG; Bender HG; Goldhirsch A
    Gynakologe; 1994 Apr; 27(2):49-63. PubMed ID: 8039743
    [No Abstract]   [Full Text] [Related]  

  • 18. [Possibilities of preventing alopecia after cytostatic therapy].
    Barzó P; Molnár L; Bátor I; Kovács B
    Orv Hetil; 1992 Jan; 133(4):256. PubMed ID: 1736238
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical application and significance of drug delivery systems in cancer chemotherapy].
    Tsukagoshi S
    Nihon Rinsho; 1989 Jun; 47(6):1295-301. PubMed ID: 2528007
    [No Abstract]   [Full Text] [Related]  

  • 20. [Principles of drug therapy of malignant tumors: determinants of the efficacy of cytostatic agents].
    Jeney A; Kralovánszky J
    Orv Hetil; 1999 Jun; 140(24):1339-45. PubMed ID: 10439634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.